This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document And Entity Information
Financial Statements
Condensed Consolidated Statements Of Operations
Condensed Consolidated Statements Of Comprehensive Earnings
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Notes to Financial Statements
General
Revenue Recognition and Accounts Receivable
Recent Accounting Pronouncements
Acquisitions and Other Transactions
Share-Based Incentive Plan
Pensions and Other Postretirement Benefits
Balance Sheet Components
Equity Method Investments
Earnings per Ordinary Share
Goodwill and Intangible Assets
Financial Instruments and Risk Management
Debt
Comprehensive Earnings
Shareholders' Equity
Segment Information
Subsidiary Guarantors
Restructuring
Collaboration and Licensing Agreements (Notes)
Litigation
Accounting Policies
General (Policies)
Revenue Recognition and Accounts Receivable (Policies)
Earnings per Ordinary Share (Policies)
Financial Instruments and Risk Management (Policies)
Segment Information (Policies)
Restructuring (Policies)
Notes Tables
Revenue Recognition and Accounts Receivable (Tables)
Acquisitions and Other Transactions (Tables)
Share-Based Incentive Plan (Tables)
Pensions and Other Postretirement Benefits (Tables)
Balance Sheet Components (Tables)
Equity Method Investments (Tables)
Earnings per Ordinary Share (Tables)
Goodwill and Intangible Assets (Tables)
Financial Instruments and Risk Management (Tables)
Debt (Tables)
Comprehensive Earnings (Tables)
Shareholders' Equity (Tables)
Segment Information (Tables)
Subsidiary Guarantors (Tables)
Restructuring (Tables)
Notes Details
Revenue Recognition and Accounts Receivable (Narrative) (Details)
Revenue Recognition and Accounts Receivable (Accounts Receivable, Net) (Details)
Acquisitions and Other Transactions (Meda) (Narrative) (Details)
Acquisitions and Other Transactions (Meda Schedule of Purchase Price Allocation) (Details)
Acquisitions and Other Transactions (Renaissance Topicals Business) (Narrative) (Details)
Acquisitions and Other Transactions (Renaissance Topicals Business Schedule of Purchase Price Allocation) (Details)
Acquisitions and Other Transactions (Pro Forma Financial Information) (Details)
Acquisitions and Other Transactions (Other Transactions) (Details)
Share-Based Incentive Plan (Narrative) (Details)
Share-Based Incentive Plan (Stock Awards) (Details)
Share-Based Incentive Plan (Nonvested Restricted Stock, Restricted Stock Units and PSUs Activity) (Details)
Pension and Other Postretirement Benefit (Narrative) (Details)
Pensions and Other Postretirement Benefits (Net Periodic Benefit Costs) (Details)
Balance Sheet Components (Narrative) (Details)
Balance Sheet Components (Inventories) (Details)
Balance Sheet Components (Prepaid Expenses and Other Current Assets) (Details)
Balance Sheet Components (Property, Plant and Equipment) (Details)
Balance Sheet Components (Other Assets) (Details)
Balance Sheet Components (Trade Accounts Payable) (Details)
Balance Sheet Components (Other Current Liabilities) (Details)
Balance Sheet Components (Other Long-term Obligations) (Details)
Equity Method Investments (Narrative) (Details)
Equity Method Investments (Income Statement) (Details)
Earnings per Ordinary Share (Narrative) (Details)
Earnings per Ordinary Share (Basic and Diluted Earnings Per Ordinary Share) (Details)
Goodwill and Intangible Assets (Narrative) (Details)
Goodwill and Intangible Assets (Changes in Carrying Amount of Goodwill) (Details)
Goodwill and Intangible Assets (Components of Intangible Assets) (Details)
Goodwill and Intangible Assets (Amortization Expense) (Details)
Goodwill and Intangibles Assets (Expected Amortization Expense) (Details)
Financial Instruments and Risk Management (Narrative) (Details)
Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Value of Derivative Instruments Derivatives Designated As Hedging Instruments) (Details)
Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Balance Sheets Fair Values of Derivative Instruments Derivatives Not Designated As Hedging Instrument) (Details)
Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Fair Value Hedging Relationships) (Details)
Financial Instruments and Risk Management Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Cash Flow Hedging Relationships) (Details) (Details)
Financial Instruments and Risk Management (Effect of Derivative Instruments on the Condensed Consolidated Statements of Comprehensive Earnings Derivatives in Net Investment Hedging Relationships (Details)
Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations Derivatives in Cash Flow Hedging Relationships) (Details)
Financial Instruments and Risk Management (Effect Of Derivative Instruments on the Condensed Consolidated Statements of Operations, Derivatives Not Designated as Hedging Instruments) (Details)
Financial Instruments and Risk Management (Financial Assets and Liabilities Carried at Fair Value) (Details)
Financial Instruments and Risk Management Financial Instruments and Risk Management (Rollforward of Contingent Consideration) (Details)
Debt (Summary of Long-Term Debt) (Details)
Debt Debt (Commercial Paper Program) (Details)
Debt (Receivables Facility) (Narrative) (Details)
Debt (2016 Revolving Credit Agreement) (Narrative) (Details)
Debt (2016 Term Credit Agreement) (Narrative) (Details)
Debt (Euro Notes) (Narrative) (Details)
Debt (Fair Value) (Narrative) (Details)
Debt (Minimum Repayments on Outstanding Borrowings) (Details)
Comprehensive Earnings (Accumulated Other Comprehensive Loss) (Details)
Comprehensive Earnings (Components Of Other Comprehensive Loss) (Details)
Shareholders' Equity (Summary Of Change In Shareholders' Equity) (Details)
Segment Information (Narrative) (Details)
Segment Information (Reconciliation Of Segment Information To Total Consolidated Information) (Details)
Subsidiary Guarantors (Narrative) (Details)
Subsidiary Guarantors Condensed Consolidating Statement of Operations (Details)
Subsidiary Guarantors Condensed Consolidating Statement of Comprehensive Earnings (Details)
Subsidiary Guarantors Condensed Consolidating Balance Sheet (Details)
Subsidiary Guarantors Condensed Consolidating Statement of Cash Flows (Details)
Restructuring (Narrative) (Details)
Restructuring (Restructuring Charges) (Details)
Litigation (Lorazepam and Clorazepate) (Narrative) (Details)
Litigation (Pricing and Medicaid Litigation) (Narrative) (Details)
Litigation (Modafinil Antitrust Litigation and FTC Inquiry) (Narrative) (Details)
Litigation (Pioglitazone) (Narrative) (Details)
Litigation (MDRP Classification of EpiPen Auto-Injector and EpiPen Jr Auto-Injector) (Details)
Litigation (Drug Pricing Matters) (Details)
Litigation (European Commission Proceedings) (Narrative) (Details)
Litigation (U.K. Competition and Markets Authority) (Narrative) (Details)
Litigation (Product Liability) (Narrative) (Details)
Litigation (Intellectual Property) (Narrative) (Details)
Litigation (Other Litigation) (Narrative) (Details)
All Reports
Rendering Log